Wall Street analysts expect that M.D.C. Holdings, Inc. (NYSE:MDC) will announce $591.92 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for M.D.C.’s earnings, with the lowest sales estimate coming in at $579.18 million and the highest estimate coming in at $603.59 million. M.D.C. posted sales of $581.71 million during the same quarter last year, which suggests a positive year-over-year growth rate of 1.8%. The company is scheduled to report its next quarterly earnings results on Tuesday, May 8th.

According to Zacks, analysts expect that M.D.C. will report full-year sales of $591.92 million for the current financial year, with estimates ranging from $2.87 billion to $3.11 billion. For the next year, analysts forecast that the business will report sales of $3.32 billion per share, with estimates ranging from $3.11 billion to $3.67 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that follow M.D.C..

M.D.C. (NYSE:MDC) last announced its quarterly earnings data on Thursday, February 1st. The construction company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.25). M.D.C. had a return on equity of 11.00% and a net margin of 5.50%. The firm had revenue of $704.26 million during the quarter, compared to the consensus estimate of $722.48 million. During the same period last year, the company earned $0.78 EPS. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year.

Several analysts have issued reports on MDC shares. Raymond James Financial raised M.D.C. from a “market perform” rating to an “outperform” rating and set a $35.00 target price on the stock in a research report on Tuesday. They noted that the move was a valuation call. UBS Group raised M.D.C. from a “market perform” rating to an “outperform” rating in a research report on Tuesday. Zacks Investment Research cut M.D.C. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Bank of America increased their target price on M.D.C. from $31.00 to $34.00 and gave the company an “underperform” rating in a research report on Friday, February 2nd. Finally, Citigroup dropped their target price on M.D.C. from $37.00 to $34.00 and set a “neutral” rating on the stock in a research report on Friday, November 3rd. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $33.71.

In other news, Director David Siegel sold 2,500 shares of the stock in a transaction on Friday, December 8th. The stock was sold at an average price of $31.83, for a total transaction of $79,575.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Herbert T. Buchwald sold 28,350 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $31.52, for a total value of $893,592.00. The disclosure for this sale can be found here. Corporate insiders own 25.30% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Meadow Creek Investment Management LLC lifted its holdings in shares of M.D.C. by 46.8% during the 4th quarter. Meadow Creek Investment Management LLC now owns 8,344 shares of the construction company’s stock valued at $266,000 after purchasing an additional 2,660 shares during the last quarter. Cornerstone Capital Management Holdings LLC. lifted its holdings in shares of M.D.C. by 102.7% during the 4th quarter. Cornerstone Capital Management Holdings LLC. now owns 18,848 shares of the construction company’s stock valued at $600,000 after purchasing an additional 9,548 shares during the last quarter. TIAA CREF Investment Management LLC lifted its holdings in shares of M.D.C. by 19.8% during the 4th quarter. TIAA CREF Investment Management LLC now owns 156,138 shares of the construction company’s stock valued at $4,978,000 after purchasing an additional 25,804 shares during the last quarter. Teachers Advisors LLC lifted its holdings in shares of M.D.C. by 9.0% during the 4th quarter. Teachers Advisors LLC now owns 81,007 shares of the construction company’s stock valued at $2,583,000 after purchasing an additional 6,697 shares during the last quarter. Finally, Raymond James & Associates lifted its holdings in shares of M.D.C. by 16.3% during the 4th quarter. Raymond James & Associates now owns 42,829 shares of the construction company’s stock valued at $1,365,000 after purchasing an additional 5,999 shares during the last quarter. Hedge funds and other institutional investors own 73.84% of the company’s stock.

M.D.C. (NYSE:MDC) opened at $30.27 on Thursday. M.D.C. has a 52 week low of $25.89 and a 52 week high of $35.18. The stock has a market capitalization of $1,674.72, a P/E ratio of 11.24, a P/E/G ratio of 0.65 and a beta of 1.36. The company has a quick ratio of 3.34, a current ratio of 10.01 and a debt-to-equity ratio of 0.78.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Stockholders of record on Wednesday, February 7th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 3.96%. The ex-dividend date is Tuesday, February 6th. This is a positive change from M.D.C.’s previous quarterly dividend of $0.25. M.D.C.’s dividend payout ratio is currently 48.10%.

TRADEMARK VIOLATION NOTICE: This story was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://theolympiareport.com/2018/02/15/m-d-c-holdings-inc-mdc-expected-to-announce-quarterly-sales-of-591-92-million.html.

About M.D.C.

M.DC Holdings, Inc is engaged in two primary operations, including homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington; Mountain, including segments located in Colorado and Utah; East, including segments located in Virginia, Florida and Maryland, which includes Pennsylvania and New Jersey; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc, StarAmerican Insurance Ltd., American Home Insurance Agency, Inc and American Home Title and Escrow Company.

Get a free copy of the Zacks research report on M.D.C. (MDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.